BECKY HODGES: Open Payments
NPI 1467237800 · MASON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 51 payments from 7 companies in 2025. Trend: 2023 $24 · 2024 $28 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $332 |
| Supernus Pharmaceuticals, Inc. | 9 | $154 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Neos Therapeutics, LP | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, Qelbree, COBENFY, REXULTI, ABILIFY MAINTENA, Adzenys XR-ODT, CAPLYTA, FANAPT.
Industry payments across OH — which companies pay providers there.
